LuminUltra Acquires Genomadix Legionella Tests and Licenses New Molecular Diagnostics
LuminUltra is expanding its leading portfolio of molecular testing solutions with the acquisition of Genomadix. This move enhances LuminUltra’s capabilities in the rapid identification and quantification of microbes in water systems—residential, commercial, and industrial—that can cause the potentially deadly Legionnaires’…